DAFNA Capital Management LLC - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 61 filers reported holding REDHILL BIOPHARMA LTD in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q2 2021$3,137,000
-6.0%
455,9330.0%0.66%
-17.2%
Q1 2021$3,337,000
+1753.9%
455,933
+1202.7%
0.79%
+716.5%
Q4 2017$180,00035,0000.10%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Ibex Investors LLC 444,301$2,284,0001.33%
683 Capital Management, LLC 999,232$5,136,0000.43%
DAFNA Capital Management LLC 35,000$180,0000.10%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$2,164,0000.08%
Migdal Insurance & Financial Holdings Ltd. 397,324$2,042,0000.05%
Claret Asset Management Corp 42,522$219,0000.05%
Orbimed Advisors 564,900$2,904,0000.04%
Altshuler Shaham Ltd 169,446$251,0000.04%
Virtu Financial LLC 60,787$312,0000.02%
MEITAV INVESTMENT HOUSE LTD 48,000$244,0000.01%
View complete list of REDHILL BIOPHARMA LTD shareholders